Hoth Therapeutics (HOTH) Competitors $1.28 -0.02 (-1.54%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$1.29 +0.01 (+0.86%) As of 07/25/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HOTH vs. APLT, RPTX, CRVO, ASRT, STRO, HOWL, SCLX, IKNA, BRNS, and MNOVShould you be buying Hoth Therapeutics stock or one of its competitors? The main competitors of Hoth Therapeutics include Applied Therapeutics (APLT), Repare Therapeutics (RPTX), CervoMed (CRVO), Assertio (ASRT), Sutro Biopharma (STRO), Werewolf Therapeutics (HOWL), Scilex (SCLX), Ikena Oncology (IKNA), Barinthus Biotherapeutics (BRNS), and MediciNova (MNOV). These companies are all part of the "pharmaceutical products" industry. Hoth Therapeutics vs. Its Competitors Applied Therapeutics Repare Therapeutics CervoMed Assertio Sutro Biopharma Werewolf Therapeutics Scilex Ikena Oncology Barinthus Biotherapeutics MediciNova Hoth Therapeutics (NASDAQ:HOTH) and Applied Therapeutics (NASDAQ:APLT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation. Is HOTH or APLT more profitable? Hoth Therapeutics' return on equity of -109.18% beat Applied Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Hoth TherapeuticsN/A -109.18% -100.22% Applied Therapeutics N/A -184.67%-84.02% Does the media refer more to HOTH or APLT? In the previous week, Hoth Therapeutics had 1 more articles in the media than Applied Therapeutics. MarketBeat recorded 4 mentions for Hoth Therapeutics and 3 mentions for Applied Therapeutics. Applied Therapeutics' average media sentiment score of 0.88 beat Hoth Therapeutics' score of 0.47 indicating that Applied Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hoth Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Applied Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, HOTH or APLT? Hoth Therapeutics has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Comparatively, Applied Therapeutics has a beta of 1.82, meaning that its share price is 82% more volatile than the S&P 500. Do analysts rate HOTH or APLT? Hoth Therapeutics presently has a consensus price target of $4.00, suggesting a potential upside of 212.50%. Applied Therapeutics has a consensus price target of $6.10, suggesting a potential upside of 1,170.83%. Given Applied Therapeutics' higher possible upside, analysts plainly believe Applied Therapeutics is more favorable than Hoth Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hoth Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25Applied Therapeutics 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do institutionals & insiders hold more shares of HOTH or APLT? 7.1% of Hoth Therapeutics shares are owned by institutional investors. Comparatively, 98.3% of Applied Therapeutics shares are owned by institutional investors. 6.9% of Hoth Therapeutics shares are owned by company insiders. Comparatively, 1.6% of Applied Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has stronger valuation & earnings, HOTH or APLT? Hoth Therapeutics has higher earnings, but lower revenue than Applied Therapeutics. Hoth Therapeutics is trading at a lower price-to-earnings ratio than Applied Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHoth TherapeuticsN/AN/A-$8.19M-$1.14-1.12Applied Therapeutics$460K147.74-$105.62M-$0.43-1.12 SummaryApplied Therapeutics beats Hoth Therapeutics on 8 of the 14 factors compared between the two stocks. Get Hoth Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HOTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOTH vs. The Competition Export to ExcelMetricHoth TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.17M$3.06B$5.69B$9.50BDividend YieldN/A2.37%4.58%4.01%P/E Ratio-1.1221.1828.1020.05Price / SalesN/A288.62432.4890.19Price / CashN/A42.7636.2258.56Price / Book1.498.378.665.87Net Income-$8.19M-$55.19M$3.25B$258.55M7 Day Performance2.40%5.88%4.22%3.73%1 Month Performance9.40%17.33%10.51%11.75%1 Year Performance53.35%4.42%34.40%18.03% Hoth Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOTHHoth Therapeutics2.9209 of 5 stars$1.28-1.5%$4.00+212.5%+58.0%$17.17MN/A-1.124Positive NewsAnalyst ForecastAPLTApplied Therapeutics4.4061 of 5 stars$0.46-0.4%$6.10+1,226.1%-90.8%$65.39M$460K-1.0730News CoverageAnalyst UpgradeRPTXRepare Therapeutics2.6591 of 5 stars$1.50-0.7%$4.50+200.0%-60.0%$64.77M$53.48M-0.50180CRVOCervoMed3.5565 of 5 stars$8.43+13.8%$22.57+167.8%-37.5%$64.49M$9.74M-3.874News CoverageAnalyst ForecastASRTAssertio2.3167 of 5 stars$0.70+3.3%$2.75+295.7%-49.7%$64.46M$124.96M-2.1720Positive NewsSTROSutro Biopharma4.162 of 5 stars$0.80+5.3%$6.11+664.3%-79.3%$64.19M$62.04M-0.27240News CoverageHOWLWerewolf Therapeutics4.0485 of 5 stars$1.40-0.7%$8.33+495.2%-50.4%$63.27M$1.88M-0.8440SCLXScilex2.3844 of 5 stars$8.60-2.9%$455.00+5,190.7%-79.9%$61.59M$56.59M-0.3080News CoverageIKNAIkena Oncology2.827 of 5 stars$1.27flat$3.00+136.2%-14.9%$61.29M$9.16M-1.4870News CoverageEarnings ReportAnalyst ForecastStock SplitHigh Trading VolumeBRNSBarinthus Biotherapeutics3.608 of 5 stars$1.97+31.5%$6.25+217.3%+22.6%$60.41M$14.97M-1.20107Positive NewsGap UpHigh Trading VolumeMNOVMediciNova1.607 of 5 stars$1.26+2.4%$7.00+455.6%+12.3%$60.33M$1M-5.4810News CoverageAnalyst ForecastGap Up Related Companies and Tools Related Companies Applied Therapeutics Alternatives Repare Therapeutics Alternatives CervoMed Alternatives Assertio Alternatives Sutro Biopharma Alternatives Werewolf Therapeutics Alternatives Scilex Alternatives Ikena Oncology Alternatives Barinthus Biotherapeutics Alternatives MediciNova Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOTH) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredStrait of Hormuz = $100 Oil?Dow Drops 540 Points, Oil Soars Middle East conflict sends markets plunging, oil jumping 8.5%. Investors fl...The Oxford Club | SponsoredThe AI Chip Trade is OUT. This is in…Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hoth Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hoth Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HOTH Stock Alerts